Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

Bioextrax publ (BIOEX) has delivered a 10.51% change over the past year, with a 52-week range between 1.60 and 4.00. What Is the Average Daily Trading Volume of Bioextrax publ (BIOEX)? The average ...

Bioextrax publ (BIOEX) has delivered a -44.07% change over the past year, with a 52-week range between 1.81 and 4.00. What Is the Average Daily Trading Volume of Bioextrax publ (BIOEX)? The average ...

Tweed-New Haven Airport (HVN) announces a significant step in its ongoing commitment to environmental safety and public health. The airport has now transitioned to BioEx Fluorine-Free Foam (F3), a ...

TOKYO & NEW YORK & DÜSSELDORF--(BUSINESS WIRE)--Asahi Kasei Medical has launched the Planova™ FG1, a next-generation virus removal filter featuring higher flux for the manufacture of biotherapeutics, ...

NEW HAVEN, Conn. — Tweed-New Haven Airport, or HVN, is taking a major step forward in its commitment to environmental safety and public health by transitioning to BioEx Fluorine-Free Foam, or F3, a ...

BIOEX Historical Data Get free historical data for BIOEX. You'll find the closing price, open, high, low, change and %change of the Bioextrax AB publ Stock for the selected range of dates. The data ...

DÜSSELDORF, TOKYO & NEW YORK CITY — May 27, 2024 — Asahi Kasei Medical has completed the construction of its third assembly plant for Planova™ virus removal filters in Nobeoka, Miyazaki, Japan, and ...

Asahi Kasei Medical Co Ltd has completed the construction of its third assembly plant for Planova virus removal filters in Nobeoka, Miyazaki, Japan. The new assembly plant for Planova filters Planova ...

The market overview was driven by data and insights collected directly from farmers and included an overview of the crop protection market, deep dive on the biological pesticides market, and review of ...

Virus filtration is one of the most important steps in ensuring viral safety during the purification of monoclonal antibodies (mAbs) and other biotherapeutics derived from mammalian cell cultures.